This article, written by an expert panel on behalf of the International Myeloma Working Group, discusses a variety of issues regarding stem cell collection and transplantation in myeloma and the role of plerixafor, providing a summary of the deliberations and conclusions.
This paper, written by an expert panel on behalf of the International Myeloma Working Group, provides consensus guidelines for the use of the serum free light chain assay in the diagnosis and management of clonal plasma cell disorders.
This paper, written by a joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology and the British Society for Bone Marrow Transplantation, reviews the available literature and made recommendations for the supportive care and management of organ-specific complications of chronic graft-versus-host disease (cGvHD).
This guideline, produced by a joint working group established by the Haemato-Oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) reviews the available literature and makes recommendations for the diagnosis and management of chronic graft-versus-host disease (GvHD).
This guideline, written by a joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT), reviews the available literature and makes recommendations for the diagnosis and management of acute graft-versus-host disease.
Carfilzomib and Pomalidomide: Recent Advances in the Treatment of Multiple Myeloma.
Highsmith KN et al. Pharmacotherapy. 2014 Jul 19. doi: 10.1002/phar.1463. [Epub ahead of print].
Impact of pomalidomide therapy in multiple myeloma: a recent survey.
Kumar A et al. J Chemother. 2014 Jul 9:1973947814Y0000000201. [Epub ahead of print].
Treatment recommendations for patients with Waldenström’s Macroglobulinemia (WM) and related disorders: consensus from the Seventh International Workshop on WM. Dimopoulos M et al. Blood. 2014 Jul 15. pii: blood-2014-03-565135. [Epub ahead of print]. Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma. Weinhold N et al. Leukemia. 2014 Jul 3. doi: 10.1038/leu.2014.208. [Epub ahead of…
European Perspective on Multiple Myeloma Treatment Strategies in 2014. Ludwig H et al. Oncologist. 2014 Jul 25. pii: theoncologist.2014-0042. [Epub ahead of print]. The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma. Joks M et al. Eur J Haematol. 2014 Jul 10. doi: 10.1111/ejh.12412.…
Hepcidin and GDF15 in anemia of multiple myeloma. Mei S et al. Int J Hematol. 2014 Jul 23. [Epub ahead of print]. Altered cytokine and chemokine profiles in multiple myeloma and precursor disease. Zingone A et al. Cytokine. 2014 Jul 17. pii: S1043-4666(14)00150-1. doi: 10.1016/j.cyto.2014.05.017. [Epub ahead of print]. Detecting monoclonal light chains in urine:…
Proteasome function is required for platelet production. Shi DS et al. J Clin Invest. 2014 Jul 25. pii: 75247. doi: 10.1172/JCI75247. [Epub ahead of print]. Overexpression of CYR61/CCN1 in the multiple myeloma microenvironment is associated with superior survival and prevention of bone disease. Johnson SK et al. Blood. 2014 Jul 24. pii: blood-2014-02-555813. [Epub ahead…